Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05004636 · ClinicalTrials.gov registry record · NA
Adductor Canal Blocks With Bupivacaine and Magnesium After Same-day Discharge Total Knee Arthroplasty Improve Post-operative Pain Relief and Decrease Opioid Consumption: a Prospective Randomized Controlled Trial
A NA study of Post-operative Pain, Acute, sponsored by Wayne State University.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 1
- Study location
NCT05004636 is a NA study of Post-operative Pain, Acute that has completed, run by Wayne State University. The registered enrollment target is 119 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05004636, a NA study of Post-operative Pain, Acute, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the addition of magnesium to bupivacaine for the post-operative adductor canal blocks (ACB) can decrease opioid consumption and improve pain management for patients after same-day discharge total knee arthroplasty (TKA). The investigators will assess whether the addition of magnesium will decrease visual analog scale (VAS) pain scores, decrease post-operative total opioid consumption (oral morphine equivalents), decrease the incidence of post-operative nausea and vomiting (PONV), and improve patient satisfaction in comparison to when magnesium is not administered.
Conditions Studied
Interventions
- DRUG Adding Magnesium as an adjuvant to the adductor canal Block (ACB) for same-day discharge total knee arthroplasty
Study Locations (1)
Michigan
- St. Joseph Mercy Oakland Hospital - Pontiac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2020-08-05 |
| Est. Completion | 2021-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05004636
The ClinicalTrials.gov registry entry for NCT05004636 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-operative Pain, Acute appearing as the primary indexed condition, and to 1 intervention - of which Adding Magnesium as an adjuvant to the adductor canal Block (ACB) for same-day discharge total knee arthroplasty is the first listed.
NCT05004636 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05004636 about?
NCT05004636 is a clinical study titled "Adductor Canal Blocks With Bupivacaine and Magnesium After Same-day Discharge Total Knee Arthroplasty Improve Post-operative Pain Relief and Decrease Opioid Consumption: a Prospective Randomized Controlled Trial". The purpose of this study is to determine whether the addition of magnesium to bupivacaine for the post-operative adductor canal blocks (ACB) can decrease opioid consumption and improve pain management for patients after same-day discharge total knee arthroplasty (TKA). The investigators will asses...
What is the current status of trial NCT05004636?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2020-08-05. Estimated completion is 2021-05-29.
What conditions does trial NCT05004636 study?
This clinical trial studies the following conditions: Post-operative Pain, Acute.
What interventions are being tested in trial NCT05004636?
The interventions under investigation include: Adding Magnesium as an adjuvant to the adductor canal Block (ACB) for same-day discharge total knee arthroplasty (DRUG).
Who is sponsoring clinical trial NCT05004636?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05004636 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.